Home | Publications | Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials

Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials

Published on: 1 March, 2020

Del Galdo F, Hartley C, Allanore Y. Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials. The Lancet Rheumatology. 2020 Mar 1;2(3):e173-e184

Link to Publication

Related Themes

Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials

Published on: 1 March, 2020

Related Themes

Musculoskeletal

Related Team Members

Professor Francesco Del Galdo

Musculoskeletal Medicine Deputy Lead

Collette Hartley

Programme Manager